Disclosed are compounds of Formula I
and pharmaceutically acceptable salts thereof, wherein R
1
, R
2
, R
3
, R
4
, and R
5
are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
Process for the oxidation of primary and secondary alcohols to aldehydes and ketones and for the oxidation of 1,2-diols to alpha-ketols and alpha-diketones
The invention provides a process for the selective oxidation of a primary or secondary alcohol to an aldehyde or ketone and for the oxidation of a 1,2-diol to an α-ketol or α-diketone which comprises contacting the alcohol or 1,2-diol with o-iodoxybenzoic acid.